Study to Investigate the Absorption, Metabolism and Excretion of Talampanel

- Healthy
- Terminated

Study Title: A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel

Teva Identifier: TAL-MB-100

ClinicalTrials.gov Identifier: NCT00868361

Study Status: Terminated

Trial Condition(s): Healthy

Interventions: Drug: Talampanel (non-radiolabeled), [14C] Talampanel

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Male

Age group: Adult

Age Range: 18 Years to 55 Years

Trial Duration: 05/01/2009 - 09/01/2009

Phase: Phase 1

Study Type

Interventional